SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-22-000038
Filing Date
2022-11-09
Accepted
2022-11-09 08:09:35
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20220930.htm   iXBRL 10-Q 1053296
2 EX-31.1 exhibit311q322.htm EX-31.1 8964
3 EX-31.2 exhibit312q322.htm EX-31.2 9059
4 EX-32.1 exhibit321q322.htm EX-32.1 5247
5 EX-32.2 exhibit322q322.htm EX-32.2 5404
  Complete submission text file 0001657312-22-000038.txt   4185374

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20220930.xsd EX-101.SCH 28250
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20220930_cal.xml EX-101.CAL 46464
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20220930_def.xml EX-101.DEF 123928
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20220930_lab.xml EX-101.LAB 362281
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20220930_pre.xml EX-101.PRE 230280
46 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20220930_htm.xml XML 583327
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 221370747
SIC: 2834 Pharmaceutical Preparations